Stockscreener 앱 받기
6.07
1.00%
0.06
전일 마감가:
$6.01
열려 있는:
$6.1
하루 거래량:
42,142
Relative Volume:
0.09
시가총액:
$76.99M
수익:
$134.00K
순이익/손실:
$-33.51M
주가수익비율:
-1.8925
EPS:
-3.2074
순현금흐름:
$-18.15M
1주 성능:
-1.38%
1개월 성능:
+11.38%
6개월 성능:
-3.34%
1년 성능:
+56.85%
1일 변동 폭
$5.83
$6.10
1주일 범위
$5.83
$6.4219
52주 변동 폭
$3.25
$13.50
Clene Inc Stock (CLNN) Company Profile
명칭
Clene Inc
전화
801-676-9695
주소
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
Compare CLNN vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLNN
Clene Inc
|
6.025 | 76.80M | 134.00K | -33.51M | -18.15M | -3.2074 |
VRTX
Vertex Pharmaceuticals Inc
|
524.31 | 134.02B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
672.45 | 68.59B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
921.42 | 58.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
320.25 | 41.76B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
191.81 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
Clene Inc Stock (CLNN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-10-04 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-07-18 | 개시 | H.C. Wainwright | Buy |
| 2022-05-02 | 개시 | Canaccord Genuity | Buy |
| 2021-09-28 | 개시 | Oppenheimer | Outperform |
Clene Inc 주식(CLNN)의 최신 뉴스
Clene Company Profile & Introduction - Moomoo
Clene Inc.(NasdaqCM: CLNN) added to Russell Microcap Value Benchmark Index - marketscreener.com
Clene Inc.(NasdaqCM: CLNN) added to Russell Microcap Index - marketscreener.com
CLNN Stock Rises 8% – Here’s What The FDA Update Means For Clene’s ALS Treatment - Stocktwits
Clene Inc.(NasdaqCM: CLNN) added to Russell 3000E Value Benchmark - marketscreener.com
Enterprise value to EBITDA forward of Clene Inc. – NASDAQ:CLNN - TradingView
Price to earnings forward of Clene Inc. – NASDAQ:CLNN - TradingView
Price to earnings forward of Clene Inc. – BOATS:CLNN - TradingView
Clene Inc Actuals & Estimates (NASDAQ:CLNN) - TradingView
Enterprise value to EBITDA forward of Clene Inc. – BOATS:CLNN - TradingView
Enterprise value to EBIT forward of Clene Inc. – BOATS:CLNN - TradingView
Enterprise value to revenue forward of Clene Inc. – BOATS:CLNN - TradingView
CLNN Forecast — Price Target — Prediction for 2027 - TradingView
Clene Inc. (CLNN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Clene Inc. (CLNN) Holds Near Support as Consolidation Persists Amid Minor DeclineLiquidity Order Flow - dars.gov.et
CLNN Q1 2026 Earnings: Clinical-Stage Biotech Delivers Narrower-Than-Expected Loss Despite No RevenueROA Comparison - dars.gov.et
Clene Inc. (CLNN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Clene Inc. (CLNNW) Institutional Confidence - TradingKey
Clene Inc. (CLNNW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Clene Inc. (CLNNW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Clene Inc. (CLNNW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Clene Inc. (CLNNW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Clene Inc. (CLNNW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Clene Inc. (CLNN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Are Medical Stocks Lagging C4 Therapeutics (CCCC) This Year? - Yahoo Finance
Clene Inc. (CLNN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Clene Inc. (CLNNW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Clene Inc. (CLNN) Institutional Confidence - TradingKey
Clene Inc. (CLNN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Clene Inc. (CLNNW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Clene Inc. (CLNNW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Clene Inc. (CLNN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Clene Inc. (CLNN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Clene Inc. (CLNN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Clene (CLNN) Chief Science Officer receives 45,000-share stock option grant - Stock Titan
Clene (CLNN) CEO receives 65,000 stock options at $5.53 exercise price - Stock Titan
Clene (CLNN) grants CFO 15,000 stock options at $5.53 strike - Stock Titan
Clene Inc. (CLNN) Gains 5.6% as Shares Approach Key ResistanceOversold Bounce Ideas - newsline.com
Clene stock jumps after FDA opens door to accelerated approval for ALS drug - MSN
TruckMountForums acquires Bane-Clene Corporation, uniting two fam - The National Law Review
TruckMountForums acquires Bane-Clene Corporation, uniting two family-owned pillars of the professional - EIN News
Clene (CLNN) may find a bottom soon, here's why you should buy the stock now - MSN
CLNN Q1 2026 Earnings: EPS Beats Expectations Amid No Revenue, Stock DeclinesOne-Time Loss Impact - newsline.com
Clene (CLNN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance
CLNN Q1 2026 Earnings: EPS Surprises to the Upside as Company Focuses on Clinical MilestonesBasic EPS Analysis - dars.gov.et
CLNN Q1 2026 Earnings: Significant EPS Beat But Stock SlidesSpecial Dividend Alert - newsline.com
CLNNClene Inc Stock Price and Quote - Finviz
CLNN Technical Analysis & Stock Price Forecast - Intellectia AI
Clene Inc. (CLNN) Shares Slide 2.24% as Stock Tests Key Support LevelsThrowback Trade - thelegaladvocate.com
CLNN Q1 2026 Earnings: EPS Beat Driven by Cost Control Amid No RevenueTangible Book Value - newsline.com
CLNN stock falls after Roth labels accelerated approval for ALS drug a 'long shot' - MSN
Clene Inc (CLNN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Clene Inc 주식 (CLNN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Ugwumba Chidozie | 10% Owner |
May 11 '26 |
Sale |
6.75 |
22,177 |
149,695 |
176,713 |
2.18%
2.70%
자본화:
|
볼륨(24시간):